Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Nephrol ; 22(1): 406, 2021 12 08.
Article in English | MEDLINE | ID: mdl-34876054

ABSTRACT

BACKGROUND: Increased perioperative pro-inflammatory biomarkers, renal hypoperfusion and ischemia reperfusion injury (IRI) heighten cardiac surgery acute kidney injury (CS-AKI) risk. Increased urinary anti-inflammatory cytokines attenuate risk. We evaluated whether blood and urinary anti-inflammatory biomarkers, when expressed as ratios with biomarkers of inflammation, hypoperfusion and IRI are increased in CS-AKI patients. METHODS: Preoperative and 24-h postoperative blood and urinary pro-inflammatory and anti-inflammatory cytokines, blood VEGF and H-FABP (hypoperfusion biomarkers), and MK, a biomarker for IRI, were measured in 401 cardiac surgery patients. Pre- and postoperative concentrations of biomarkers and selected ratios thereof, were compared between non-CS-AKI and CS-AKI patients. RESULTS: Compared with non-CS-AKI, blood pro-inflammatory (pre- and post-op TNFα, IP-10, IL-12p40, MIP-1α, NGAL; pre-op IL-6; post-op IL-8, MK) and anti-inflammatory (pre- and post-op sTNFsr1, sTNFsr2, IL-1RA) biomarkers together with urinary pro-inflammatory (pre- and post-op uIL-12p40; post-op uIP-10, uNGAL) and anti-inflammatory (pre- and post-op usTNFsr1, usTNFsr2, uIL-1RA) biomarkers, were significantly higher in CS-AKI patients. Urinary anti-inflammatory biomarkers, when expressed as ratios with biomarkers of inflammation (blood and urine), hypoperfusion (blood H-FABP and VEGF) and IRI (blood MK) were decreased in CS-AKI. In contrast, blood anti-inflammatory biomarkers expressed as similar ratios with blood biomarkers were increased in CS-AKI. CONCLUSIONS: The urinary anti-inflammatory response may protect against the injurious effects of perioperative inflammation, hypoperfusion and IRI. These finding may have clinical utility in bioprediction and earlier diagnosis of CS-AKI and informing future therapeutic strategies for CS-AKI patients.


Subject(s)
Acute Kidney Injury/blood , Acute Kidney Injury/urine , Cardiac Surgical Procedures , Cytokines/blood , Cytokines/urine , Postoperative Complications/blood , Postoperative Complications/urine , Aged , Biomarkers/blood , Biomarkers/urine , Female , Humans , Male , Middle Aged
2.
J Cardiothorac Vasc Anesth ; 34(8): 2269-2271, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32122732

ABSTRACT

Stroke is an uncommon presentation in young adults, with different causes and risks factors implicated. Cardiogenic cerebral embolus is one of the most common causes in younger patients and must be considered in the investigation of young patients presenting with stroke. The authors describe a case of a young patient presenting with stroke as a result of distal embolization from a previously undiagnosed congenital mitral valve defect.


Subject(s)
Intracranial Embolism , Stroke , Humans , Mitral Valve/diagnostic imaging , Mitral Valve/surgery , Stroke/diagnostic imaging , Stroke/etiology , Young Adult
3.
Sci Rep ; 9(1): 16963, 2019 11 18.
Article in English | MEDLINE | ID: mdl-31740699

ABSTRACT

Acute kidney injury (AKI) following cardiac surgery significantly increases morbidity and mortality risks. Improving existing clinical methods of identifying patients at risk of perioperative AKI may advance management and treatment options. This study investigated whether a combination of biomarkers and clinical factors pre and post cardiac surgery could stratify patients at risk of developing AKI. Patients (n = 401) consecutively scheduled for elective cardiac surgery were prospectively studied. Clinical data was recorded and blood samples were tested for 31 biomarkers. Areas under receiver operating characteristic (AUROCs) were generated for biomarkers pre and postoperatively to stratify patients at risk of AKI. Preoperatively sTNFR1 had the highest predictive ability to identify risk of developing AKI postoperatively (AUROC 0.748). Postoperatively a combination of H-FABP, midkine and sTNFR2 had the highest predictive ability to identify AKI risk (AUROC 0.836). Preoperative clinical risk factors included patient age, body mass index and diabetes. Perioperative factors included cardio pulmonary bypass, cross-clamp and operation times, intra-aortic balloon pump, blood products and resternotomy. Combining biomarker risk score (BRS) with clinical risk score (CRS) enabled pre and postoperative assignment of patients to AKI risk categories. Combining BRS with CRS will allow better management of cardiac patients at risk of developing AKI.


Subject(s)
Acute Kidney Injury/etiology , Biomarkers/blood , Cardiac Surgical Procedures/adverse effects , Postoperative Complications/etiology , Acute Kidney Injury/blood , Aged , Algorithms , Body Mass Index , Cardiopulmonary Bypass/adverse effects , Female , Humans , Male , Middle Aged , Postoperative Complications/blood , Preoperative Period , ROC Curve , Receptors, Tumor Necrosis Factor, Type I/blood , Receptors, Tumor Necrosis Factor, Type II/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...